BU-NOT-SET

CONTACT US
Women in leadership
  • Corporate
Eyes
Insight
The state of the oral solid dose development and manufacturing market
  • Drug product
Eyes
Insight
Characterising APIs is Essential for Combo Drug Formulations
  • Drug substance
Eyes
Insight
Outsourcing stability testing
  • Analytical chemistry
Eyes
Insight
Brexit: What’s next for UK pharma?
  • Industry trends
Eyes
Insight
Navigating approval filings choppy international waters
  • Drug substance
Eyes
Insight
Regulatory requirements for drug substances
  • Drug substance
Product check
Insight
The QbD approach: Key advantages in clinical and commercial phases
  • Analytical chemistry
Lab
Insight
Sustainability report 2020
  • Sustainability
Report
Report
Insight
  • Manufacturing
  • Sustainability
Sustainable drug delivery systems: Collaborative innovation to shrink pharma’s packaging footprint
eBook
  • Drug product
  • Manufacturing
ReciPredict - How value by design can bring your drug to market faster
eBook
  • Biologics
  • Manufacturing
Enhancing stability for next-generation therapeutics with lyophilisation
Case study
  • Drug product
  • Manufacturing
Accelerating tablet tech-transfer through predictive modelling
Case study
  • Drug product
  • Manufacturing
Tackling assay variability in liquid vials: A data-driven approach to overcoming challenges
Fact sheet
  • Drug product
  • Manufacturing
Scalable solutions for high potent manufacturing
Insight
  • Drug product
  • Manufacturing
The stabilising power of lyophilisation in next-generation therapeutics
Insight
  • Drug product
  • Manufacturing
Unlocking the power of advanced sterile packaging
Fact sheet
  • Biologics
  • Manufacturing
Advancing continuous bioprocessing with Recimagine™